HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis.

AbstractOBJECTIVE:
Although lung transplantation is viewed as an acceptable option for patients with end-stage idiopathic pulmonary fibrosis, the survival benefit of this approach is still debated. This study examined whether there was a survival benefit of lung transplantation in a cohort of patients referred to our transplant center with a diagnosis of idiopathic pulmonary fibrosis according to American Thoracic Society criteria.
METHODS:
Forty-six patients accepted for lung transplantation during a 12-year period with a diagnosis of idiopathic pulmonary fibrosis form the basis of this study. Survival benefit offered by lung transplantation was assessed using Cox proportional-hazards modeling, with patients on a waiting list as the control group.
RESULTS:
Twenty-eight patients underwent lung transplantation (27 single and 1 double), 16 patients died while waiting, and 2 patients remained on the active waiting list. Diagnosis of idiopathic pulmonary fibrosis was made on histologic examination of the explanted lung or lung biopsy before lung transplantation. There was a pattern of usual interstitial pneumonia in 31 cases (67%). The 15 remaining patients fulfilled all American Thoracic Society criteria for idiopathic pulmonary fibrosis. The median waiting time for organs was 51 days. Survival after lung transplantation was 79.4% at 1 year, 63.5% at 2 years, and 39% at 5 years. The multivariable analysis showed that lung transplantation reduced the risk of death by 75% (95% confidence interval, 8%-86%; P =.03) after adjustment on potential confounding variables.
CONCLUSIONS:
Lung transplantation is effective in improving the survival of selected patients affected by idiopathic pulmonary fibrosis.
AuthorsGabriel Thabut, Hervé Mal, Yves Castier, Odile Groussard, Olivier Brugière, Rolana Marrash-Chahla, Guy Lesèche, Michel Fournier
JournalThe Journal of thoracic and cardiovascular surgery (J Thorac Cardiovasc Surg) Vol. 126 Issue 2 Pg. 469-75 (Aug 2003) ISSN: 0022-5223 [Print] United States
PMID12928646 (Publication Type: Comparative Study, Journal Article)
Topics
  • Adult
  • Biopsy
  • Cohort Studies
  • Exercise Tolerance (physiology)
  • Female
  • Follow-Up Studies
  • France
  • Humans
  • Lung (pathology, physiopathology)
  • Lung Transplantation (mortality)
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Pulmonary Fibrosis (etiology, mortality, surgery)
  • Severity of Illness Index
  • Statistics as Topic
  • Survival Analysis
  • Time Factors
  • Total Lung Capacity (physiology)
  • Treatment Outcome
  • Waiting Lists

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: